Oxford Talks
Toggle navigation
Help
Login
Anderson Ryan
University of Oxford
Events this person is hosting:
Monday 2 November 2015 (4th Week, Michaelmas Term)
11:00
-
Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Dr Barry Davis
( AstraZeneca)
Department of Oncology